{"id":8820,"date":"2026-03-19T15:30:00","date_gmt":"2026-03-19T08:30:00","guid":{"rendered":"https:\/\/www.globenewswire.com\/news-release\/2026\/03\/19\/3258774\/0\/en\/BOOST-Pharma-Appoints-Leading-Biopharma-Leader-Elaine-Jones-as-Chair.html3258774"},"modified":"2026-03-19T15:33:34","modified_gmt":"2026-03-19T08:33:34","slug":"boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair","status":"publish","type":"post","link":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/","title":{"rendered":"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair"},"content":{"rendered":"\n<ul type=\"disc\">\n<li><em>Seasoned life science investor, executive and board leader to support next phase of growth as BOOST Pharma advances BT-101, a promising and potentially disease-modifying therapy for osteogenesis imperfecta<\/em><\/li>\n<\/ul>\n<p align=\"justify\">STOCKHOLM, March 19, 2026 (GLOBE NEWSWIRE) &#8212; BOOST Pharma (\u201cBOOST\u201d or the \u201cCompany), a clinical\u2011stage biopharmaceutical company developing novel, first\u2011in\u2011class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases, today announced the appointment of highly respected industry leader Elaine Jones, PhD, as Chair of its Board of Directors. Elaine succeeds Ingelise Saunders, who will remain on the Board.<\/p>\n<p align=\"justify\">Elaine Jones is a distinguished biopharmaceutical executive, venture investor, and board leader, bringing more than two decades of experience shaping and scaling innovative life science companies. Over her career, she has served on more than 35 company boards and held senior roles across the global biotechnology ecosystem, including as Vice President of Venture Capital at Pfizer Ventures, where she oversaw strategic investments in companies aligned with Pfizer\u2019s R&amp;D priorities, and earlier in leadership roles at GSK\u2019s corporate venture fund, SR One.<\/p>\n<p align=\"justify\">Her appointment marks an important inflection point for BOOST Pharma as it advances BT-101, its lead off-the-shelf cell therapy for osteogenesis imperfecta (OI), also known as Brittle Bone Disease, toward Phase III clinical development. BT-101 has shown promising data in early clinical trials demonstrating reductions in fractures among affected children, supporting its potential as the first disease-modifying therapy for this severe rare condition.<\/p>\n<p align=\"justify\"><strong>Hans Schambye, Chief Executive Officer of BOOST Pharma, said<\/strong>: \u201cElaine\u2019s unique combination of strategic insight, investment acumen and deep board leadership experience will be invaluable as we prepare BT\u2011101 for late\u2011stage development and drive the Company into its next phase of growth. I would also like to express my sincere thanks to Ingelise Saunders for her outstanding service as Chair. She has guided BOOST through critical milestones and challenging periods with exceptional commitment, and we are delighted she will continue contributing as a Board Director.\u201d<\/p>\n<p align=\"justify\">Elaine currently serves on the boards of CytomX Therapeutics, HBM Healthcare Investments AG, and NextCure, is Chair of Mironid, and is also a member of the Board of the Novartis Venture Fund.<\/p>\n<p align=\"justify\"><strong>Dr. Elaine Jones, incoming Chair of BOOST Pharma, commented:<\/strong> \u201cBOOST Pharma has the scientific vision, clinical ambition, and highly experienced team to position the company for long-term success. BT\u2011101 is an especially compelling program, with the potential to meaningfully improve the lives of children living with osteogenesis imperfecta. I look forward to supporting BOOST as it advances this promising therapy into late\u2011stage development and builds further value for patients, partners, and investors.\u201d<\/p>\n<p align=\"justify\">As BOOST Pharma enters this next stage of growth, the Company will meet with partners and investors at key industry events this spring, including BIO-Europe Spring and LSX World Congress Europe, where CEO Hans Schambye will participate in expert panel discussions.<\/p>\n<p align=\"justify\"><strong>For more information, please contact:<\/strong><\/p>\n<p align=\"justify\"><strong>Optimum Strategic Communications<\/strong><br \/>Zoe Bolt | Vareen Outhonesack | Nellie Stephens<\/p>\n<p>Tel: +44 (0) 20 388 296 21<\/p>\n<p>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YGdWBXE-osd7Q71Lqxpncjv_zk-CLda_ZUBVCya-6zszWNxM-Cvyfon8tYaAy8Ey8lA6cZsUwV0nAO_V3H_NDeUhjID7X1tOW8gOqFYAuQVOXvx-S591BB0u8Q6gYysV\" rel=\"nofollow\" target=\"_blank\" title=\"boostpharma@optimumcomms.com\">boostpharma@optimumcomms.com<\/a> <\/p>\n<p align=\"justify\"><strong>About BOOST Pharma <\/strong><\/p>\n<p align=\"justify\">BOOST Pharma ApS is a clinical\u2011stage biotechnology company developing novel, first\u2011in\u2011class off-the-shelf stem cell therapies for rare, debilitating pediatric skeletal diseases. The Company\u2019s lead program, BT\u2011101, is an allogeneic mesenchymal stem cell therapy for osteogenesis imperfecta, a severe rare bone disorder, and has received Orphan Drug Designation in both the U.S. and Europe. BT\u2011101 is currently advancing toward a planned Phase III clinical trial.<\/p>\n<p align=\"justify\">BOOST is backed by a strong syndicate of life\u2011science investors, including Industrifonden, Karolinska Development, and Sound Bioventures, who support the Company\u2019s strategy focused on high\u2011impact science, capital\u2011efficient development, and clear pathways to market. The Company is led by a team with deep experience in biotech innovation, clinical execution, and value creation. For further information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QClJIN75EYf4WpOiewDQCEuR162iYQ0IIHsdGFn7ysnlbBITWTCPAXzcS9liO5zXQIX1SiAmBC6fa58Li8fTggYCOkzaGEWZwVB9_RdrYd0=\" rel=\"nofollow\" target=\"_blank\" title>https:\/\/boostpharma.com\/<\/a>.<\/p>\n<p><strong>About Osteogenesis Imperfecta <\/strong><\/p>\n<p align=\"justify\">Osteogenesis Imperfecta (OI), also known as Brittle Bone Disease, is a rare and devastating genetic disorder characterized by extremely fragile bones, reduced bone mass, and frequent fractures, often beginning in infancy. Individuals with OI may experience dozens to hundreds of fractures over a lifetime, along with loose joints, weakened teeth, and significant skeletal deformities. Beyond bone fragility, people living with OI frequently face muscle weakness, fatigue, curved bones, scoliosis, respiratory complications, early\u2011onset hearing loss, and short stature, all contributing to substantial impacts on overall health and quality of life.<\/p>\n<p align=\"justify\">There are currently no FDA or EMA\u2011approved disease\u2011modifying therapies for OI; existing management is purely supportive, aimed at reducing fracture risk and preserving mobility. OI affects an estimated 1 in 15,000 people globally, underscoring the urgent need for safe and effective treatments.<\/p>\n<p>A photo accompanying this announcement is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QClJIN75EYf4WpOiewDQCLl3wR41gxE_segyCklRNM8kXKFAneuwzb7Rk4JB7mM-57Qn_Hk69mkaxoavdv6SUrT2gqdwIk-Adcy_m4hkXYL0uj-5knwMLawrv9Zbrm8t-uBbfWOyxnx0LYYQYCswNOuFGg3nkWbhbv_w6QzeLIRwGXc8CjLOqqrCYvGeletxkbD7fxGoMFoJA5_YCBACF8w6lFrVIQcvPQ5wdWhhceUEXHbQDIX6dxjBT_MHyHOn66fmtmQUrql-lTiIyK92jg==\" rel=\"nofollow\" target=\"_blank\" title>https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/8d6a4ee5-196c-4500-b705-394f7e47eec1<\/a><\/p>\n<p><img decoding=\"async\" alt src=\"https:\/\/ml-eu.globenewswire.com\/media\/MDIzY2RlNGEtOWJiYy00YzU5LTkzNWMtZTkxZWE3MDVmYmM4LTcwMDAyNzE4Mi0yMDI2LTAzLTE5LWVu\/tiny\/BOOST-Pharma.png\" referrerpolicy=\"no-referrer-when-downgrade\">  <\/p>\n","protected":false},"excerpt":{"rendered":"<p>  Elaine Jones   Chair, Board of Directors, BOOST Pharma<br \/>\nSeasoned life science investor, executive and board leader to support next phase of growth as BOOST Pharma advances BT-101, a promising and potentially disease-modifying therapy for osteogenesis imperfecta STOCKHOLM, March 19, 2026 (GLOBE NEWSWIRE) &#8212; BOOST Pharma (\u201cBOOST\u201d or the \u201cCompany), a clinical\u2011stage biopharmaceutical company developing novel, first\u2011in\u2011class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases, today announced the appointment of highly respected industry leader Elaine Jones, PhD,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":8821,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[75,1406],"tags":[],"class_list":["post-8820","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-globenewswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair<\/title>\n<meta name=\"description\" content=\"Elaine Jones  Chair, Board of Directors, BOOST Pharma Seasoned life science investor, executive and board leader to support next phase of growth as BOOST Pharma advances BT-101, a promising and potentially disease-modifying therapy for osteogenesis imperfecta STOCKHOLM, March 19, 2026 (GLOBE NEWSWIRE) -- BOOST Pharma (\u201cBOOST\u201d or the \u201cCompany), a clinical\u2011stage biopharmaceutical company developing novel, first\u2011in\u2011class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases, today announced the appointment of highly respected industry leader Elaine Jones, PhD,...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/Elaine%20Jones%20%20Chair,%20Board%20of%20Directors,%20BOOST%20Pharma%20Seasoned%20life%20science%20investor,%20executive%20and%20board%20leader%20to%20support%20next%20phase%20of%20growth%20as%20BOOST%20Pharma%20advances%20BT-101,%20a%20promising%20and%20potentially%20disease-modifying%20therapy%20for%20osteogenesis%20imperfecta%20STOCKHOLM,%20March%2019,%202026%20(GLOBE%20NEWSWIRE)%20--%20BOOST%20Pharma%20(\u201cBOOST\u201d%20or%20the%20\u201cCompany),%20a%20clinical\u2011stage%20biopharmaceutical%20company%20developing%20novel,%20first\u2011in\u2011class%20off-the-shelf%20cell%20therapies%20for%20rare,%20debilitating%20pediatric%20skeletal%20diseases,%20today%20announced%20the%20appointment%20of%20highly%20respected%20industry%20leader%20Elaine%20Jones,%20PhD,...\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair\" \/>\n<meta property=\"og:description\" content=\"Elaine Jones  Chair, Board of Directors, BOOST Pharma Seasoned life science investor, executive and board leader to support next phase of growth as BOOST Pharma advances BT-101, a promising and potentially disease-modifying therapy for osteogenesis imperfecta STOCKHOLM, March 19, 2026 (GLOBE NEWSWIRE) -- BOOST Pharma (\u201cBOOST\u201d or the \u201cCompany), a clinical\u2011stage biopharmaceutical company developing novel, first\u2011in\u2011class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases, today announced the appointment of highly respected industry leader Elaine Jones, PhD,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/\" \/>\n<meta property=\"og:site_name\" content=\"Crypto Insider\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/yourcryptoinsider\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-19T08:30:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T08:33:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/MDIzY2RlNGEtOWJiYy00YzU5LTkzNWMtZTkxZWE3MDVmYmM4LTcwMDAyNzE4Mi0yMDI2LTAzLTE5LWVu\/tiny\/BOOST-Pharma.png\" \/>\n<meta name=\"author\" content=\"Crypto Insider\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Crypto Insider\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/\"},\"author\":{\"name\":\"Crypto Insider\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\"},\"headline\":\"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair\",\"datePublished\":\"2026-03-19T08:30:00+00:00\",\"dateModified\":\"2026-03-19T08:33:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/\"},\"wordCount\":790,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair.gif\",\"articleSection\":[\"Business\",\"GlobeNewswire\"],\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/\",\"name\":\"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair - Crypto Insider\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair.gif\",\"datePublished\":\"2026-03-19T08:30:00+00:00\",\"dateModified\":\"2026-03-19T08:33:34+00:00\",\"description\":\"Crypto and Blockchain News\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair.gif\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair.gif\",\"width\":1,\"height\":1},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Business\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/business\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"name\":\"Crypto Insider\",\"description\":\"Crypto and Blockchain News\",\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\",\"name\":\"Crypto Insider\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"width\":2048,\"height\":2048,\"caption\":\"Crypto Insider\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/yourcryptoinsider\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/vietnaminsider\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\",\"name\":\"Crypto Insider\",\"description\":\"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain\",\"sameAs\":[\"https:\\\/\\\/cryptoinsider.asia\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair","description":"Elaine Jones  Chair, Board of Directors, BOOST Pharma Seasoned life science investor, executive and board leader to support next phase of growth as BOOST Pharma advances BT-101, a promising and potentially disease-modifying therapy for osteogenesis imperfecta STOCKHOLM, March 19, 2026 (GLOBE NEWSWIRE) -- BOOST Pharma (\u201cBOOST\u201d or the \u201cCompany), a clinical\u2011stage biopharmaceutical company developing novel, first\u2011in\u2011class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases, today announced the appointment of highly respected industry leader Elaine Jones, PhD,...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"Elaine Jones  Chair, Board of Directors, BOOST Pharma Seasoned life science investor, executive and board leader to support next phase of growth as BOOST Pharma advances BT-101, a promising and potentially disease-modifying therapy for osteogenesis imperfecta STOCKHOLM, March 19, 2026 (GLOBE NEWSWIRE) -- BOOST Pharma (\u201cBOOST\u201d or the \u201cCompany), a clinical\u2011stage biopharmaceutical company developing novel, first\u2011in\u2011class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases, today announced the appointment of highly respected industry leader Elaine Jones, PhD,...","og_locale":"vi_VN","og_type":"article","og_title":"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair","og_description":"Elaine Jones  Chair, Board of Directors, BOOST Pharma Seasoned life science investor, executive and board leader to support next phase of growth as BOOST Pharma advances BT-101, a promising and potentially disease-modifying therapy for osteogenesis imperfecta STOCKHOLM, March 19, 2026 (GLOBE NEWSWIRE) -- BOOST Pharma (\u201cBOOST\u201d or the \u201cCompany), a clinical\u2011stage biopharmaceutical company developing novel, first\u2011in\u2011class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases, today announced the appointment of highly respected industry leader Elaine Jones, PhD,...","og_url":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/","og_site_name":"Crypto Insider","article_publisher":"https:\/\/www.facebook.com\/yourcryptoinsider","article_published_time":"2026-03-19T08:30:00+00:00","article_modified_time":"2026-03-19T08:33:34+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/MDIzY2RlNGEtOWJiYy00YzU5LTkzNWMtZTkxZWE3MDVmYmM4LTcwMDAyNzE4Mi0yMDI2LTAzLTE5LWVu\/tiny\/BOOST-Pharma.png","type":"","width":"","height":""}],"author":"Crypto Insider","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Crypto Insider","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"4 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/#article","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/"},"author":{"name":"Crypto Insider","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6"},"headline":"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair","datePublished":"2026-03-19T08:30:00+00:00","dateModified":"2026-03-19T08:33:34+00:00","mainEntityOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/"},"wordCount":790,"commentCount":0,"publisher":{"@id":"https:\/\/cryptoinsider.asia\/#organization"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/03\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair.gif","articleSection":["Business","GlobeNewswire"],"inLanguage":"vi","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/","url":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/","name":"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair - Crypto Insider","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/#primaryimage"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/03\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair.gif","datePublished":"2026-03-19T08:30:00+00:00","dateModified":"2026-03-19T08:33:34+00:00","description":"Crypto and Blockchain News","breadcrumb":{"@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/"]}]},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/#primaryimage","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/03\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair.gif","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/03\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair.gif","width":1,"height":1},{"@type":"BreadcrumbList","@id":"https:\/\/cryptoinsider.asia\/vi\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cryptoinsider.asia\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/cryptoinsider.asia\/category\/news\/"},{"@type":"ListItem","position":3,"name":"Business","item":"https:\/\/cryptoinsider.asia\/category\/business\/"},{"@type":"ListItem","position":4,"name":"BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair"}]},{"@type":"WebSite","@id":"https:\/\/cryptoinsider.asia\/vi\/#website","url":"https:\/\/cryptoinsider.asia\/vi\/","name":"Crypto Insider","description":"Crypto and Blockchain News","publisher":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cryptoinsider.asia\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Organization","@id":"https:\/\/cryptoinsider.asia\/vi\/#organization","name":"Crypto Insider","url":"https:\/\/cryptoinsider.asia\/vi\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","width":2048,"height":2048,"caption":"Crypto Insider"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/yourcryptoinsider","https:\/\/www.linkedin.com\/company\/vietnaminsider"]},{"@type":"Person","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6","name":"Crypto Insider","description":"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain","sameAs":["https:\/\/cryptoinsider.asia"]}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/03\/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair.gif","jetpack-related-posts":[],"jetpack_likes_enabled":false,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/8820","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/comments?post=8820"}],"version-history":[{"count":0,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/8820\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media\/8821"}],"wp:attachment":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media?parent=8820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/categories?post=8820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/tags?post=8820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}